Issue
Alert me when new journal issues are available via or via
Aims & scope/editorial board page iii Full-Text PDF (44 KB)
Preface
Immune therapy in haematological malignancies Martin S. Tallman pages 635-636 Full Text | Full-Text PDF (38 KB)
1
The immune system as a foundation for immunologic therapy and hematologic malignancies: a historical perspective Frédéric Baron, Rainer Storb pages 637-653 Abstract | Full Text | Full-Text PDF (304 KB)
2
Radioimmunotherapy for B-cell non-Hodgkin lymphoma Thomas E. Witzig pages 655-668 Abstract | Full Text | Full-Text PDF (142 KB)
3
Radioimmunotherapeutic strategies in autologous hematopoietic stem-cell transplantation for malignant lymphoma David J. Inwards, Jeffrey C. Cilley, Jane N. Winter pages 669-684 Abstract | Full Text | Full-Text PDF (196 KB)
4
BL22 and lymphoid malignancies Robert J. Kreitman, Ira Pastan pages 685-699 Abstract | Full Text | Full-Text PDF (303 KB)
5
Novel antibody-based therapy for acute lymphoblastic leukaemia Nicola Gökbuget, Dieter Hoelzer pages 701-713 Abstract | Full Text | Full-Text PDF (196 KB)
6
Monoclonal antibodies and immunoconjugates in acute myeloid leukemia Sergio Amadori, Roberto Stasi pages 715-736 Abstract | Full Text | Full-Text PDF (241 KB)
7
Donor leukocyte infusions in myeloid malignancies: new strategies David L. Porter, Joseph H. Antin pages 737-755 Abstract | Full Text | Full-Text PDF (254 KB)
8
Immunomodulation in myelodysplastic syndromes Mikkael A. Sekeres, Alan List pages 757-767 Abstract | Full Text | Full-Text PDF (109 KB)
9
Thalidomide and lenalidomide in multiple myeloma Amitabha Mazumder, Sundar Jagannath pages 769-780 Abstract | Full Text | Full-Text PDF (121 KB)
10
Monoclonal antibody combinations in CLL: evolving strategies Stefan Faderl, Susan O'Brien, Michael J. Keating pages 781-793 Abstract | Full Text | Full-Text PDF (126 KB)
11
Alemtuzumab in T-cell lymphoproliferative disorders Claire E. Dearden, Estella Matutes pages 795-810 Abstract | Full Text | Full-Text PDF (203 KB)
12
Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation Jakob R. Passweg, Ulrike Koehl, Lutz Uharek, Sandrine Meyer-Monard, André Tichelli pages 811-824 Abstract | Full Text | Full-Text PDF (165 KB)
13
Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML Dietger Niederwieser, Thoralf Lange, Michael Cross, Nadesda Basara, Haifa Al-Ali pages 825-838 Abstract | Full Text | Full-Text PDF (236 KB)
14
Immune-cell treatment of Epstein–Barr-virus-associated lymphoproliferative disorders Lode J. Swinnen pages 839-847 Abstract | Full Text | Full-Text PDF (97 KB)
Index pages I-VI Full-Text PDF (73 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
